The Taibo? Sildenafil Citrate Orally Disintegrating Tablets (50mg), which is our company's new dosage form and deemed to have passed the consistency evaluation, was recently approved for marketing.
More2017 President Shionogi Award - Two projects of Chang Ao won award
MoreNanjing Chang Ao Pharmaceutical Co., Limited organized a whip egg (a card game) competition on June 10, 2017.
MoreIn April of this year, a call for President Teshirogi Award (2017) was made as usual. And a call for posters for the recognition activities was made at the same time this year, and Mr. Jin from C&O designed and produced the poster.
MoreShenzhen, [September 29] C&O today announces the launch of its first next-generation proton pump inhibitor, Rabeprazole Sodium for Injection (Aobo Ping?), in China. Aubergine? is a self-developed product of C&O.
More